GPB Scientific
Richmond, US · Delaware corporation · 2 known investors
Founders & leadership
MD
Michael D. GrishamChief Executive Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements$42.3M disclosed across 9 rounds · 2013–2022
▶$3.6MraisedSep 2022 · 40 investors · BiotechnologyRule 506(b)
▶$3.6MraisedSep 2022 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $10M
- Amount sold
- $3.6M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedApr 2021 · 39 investors · BiotechnologyRule 506(b)
▶$17MraisedApr 2021 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $18M
- Amount sold
- $17M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.5MraisedMar 2020 · 2 investors · BiotechnologyRule 506(b)
▶$15.5MraisedMar 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $25M
- Amount sold
- $15.5M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedSep 2019 · 23 investors · BiotechnologyRule 506(b)
▶$1.5MraisedSep 2019 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Sales commissions
- $200K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$500KraisedJun 2018 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $10M
- Amount sold
- $500K
- Sales commissions
- $104.1K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- May 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$810KraisedFeb 2017 · 21 investors · BiotechnologyRule 506(b)
▶$810KraisedFeb 2017 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $810K
- Sales commissions
- $8.4K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- Feb 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedJan 2016 · 12 investors · BiotechnologyRule 506(b)
▶$1.4MraisedJan 2016 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.4M
- Sales commissions
- $87K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- Jan 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$110KraisedJul 2015 · 6 investors · BiotechnologyRule 506(b)
▶$110KraisedJul 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $2M
- Amount sold
- $110K
- Sales commissions
- $7.7K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are GPB Scientific's investors?
- GPB Scientific's investors include Amgen Ventures, Vensana Capital.
- How much funding has GPB Scientific raised?
- GPB Scientific has disclosed $42.3M raised across 9 rounds.
- Where is GPB Scientific headquartered?
- GPB Scientific is headquartered in Richmond, US.